Jyong Biotech Ltd. Ordina... (MENS)
NASDAQ: MENS
· Real-Time Price · USD
61.50
-2.92 (-4.53%)
At close: Sep 12, 2025, 3:59 PM
62.35
1.38%
After-hours: Sep 12, 2025, 05:44 PM EDT
-4.53% (1D)
| Bid | 54.15 |
| Market Cap | 4.57B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.04 |
| PE Ratio (ttm) | -1537.5 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 70.35 |
| Volume | 342,949 |
| Avg. Volume (20D) | 233,216.5 |
| Open | 64.42 |
| Previous Close | 64.42 |
| Day's Range | 58.21 - 67.00 |
| 52-Week Range | 6.01 - 67.00 |
| Beta | n/a |
About MENS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MENS
Website n/a
1 month ago · seekingalpha.com
Jyong Biotech's Plant‑Based Pipeline Targets Huge Markets But Risks RemainJyong Biotech develops botanical drugs for urinary disorders. Their lead asset is clearly MCS‑2, which is currently restarting Phase 3 trials after a previous FDA setback. Their pipeline targets large...
